Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:58:06.197Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:58:06.197Z.

Quote observation: 2026-10-06T19:55:23.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,348,067,750
Total debt · period ending 2026-05-31: 58,143,000
Cash · period ending 2026-05-31: 67,685,000
TTM free cash flow · period ending 2026-05-31: -304,527,000

FMP input reference: 3dc852dbbee421fd1d0f2104bcbe090e37fdd8a7ae3294fdff0c13dff3b4c360

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

NRIX EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NRIX Competitors' EV/FCF Ratio

NRIX

Nurix Therapeutics, Inc.

Current

Market Cap

$2.35B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

UFPT

UFP Technologies, Inc.

vs NRIX

Market Cap

$2.35B

EV/FCF Ratio

40.28x

TTM Avg

26.99x

3Y Avg

39.76x

5Y Avg

80.04x

ADMA

ADMA Biologics, Inc.

vs NRIX

Market Cap

$2.35B

EV/FCF Ratio

20.72x

TTM Avg

65.64x

3Y Avg

95.37x

5Y Avg

95.37x

IRON

Disc Medicine, Inc.

vs NRIX

Market Cap

$2.37B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLOV

Clover Health Investments, Corp.

vs NRIX

Market Cap

$2.38B

EV/FCF Ratio

29.41x

TTM Avg

35.75x

3Y Avg

35.25x

5Y Avg

31.41x

LQDA

Liquidia Corporation

vs NRIX

Market Cap

$2.30B

EV/FCF Ratio

35.47x

TTM Avg

106.68x

3Y Avg

106.68x

5Y Avg

106.68x

RXRX

Recursion Pharmaceuticals, Inc.

vs NRIX

Market Cap

$2.41B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRMY

Harmony Biosciences Holdings, Inc.

vs NRIX

Market Cap

$2.28B

EV/FCF Ratio

5.30x

TTM Avg

4.85x

3Y Avg

7.14x

5Y Avg

13.46x

SUPN

Supernus Pharmaceuticals, Inc.

vs NRIX

Market Cap

$2.47B

EV/FCF Ratio

124.08x

TTM Avg

54.29x

3Y Avg

27.10x

5Y Avg

23.78x

ALMR

Alamar Biosciences, Inc.

vs NRIX

Market Cap

$2.19B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Nurix Therapeutics, Inc. (NRIX)	$2.35B	N/A	N/A	N/A	N/A
UFP Technologies, Inc. (UFPT)vs ›	$2.35B	40.28x	26.99x	39.76x	80.04x
ADMA Biologics, Inc. (ADMA)vs ›	$2.35B	20.72x	65.64x	95.37x	95.37x
Disc Medicine, Inc. (IRON)vs ›	$2.37B	N/A	N/A	N/A	N/A
Clover Health Investments, Corp. (CLOV)vs ›	$2.38B	29.41x	35.75x	35.25x	31.41x
Liquidia Corporation (LQDA)vs ›	$2.30B	35.47x	106.68x	106.68x	106.68x
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.41B	N/A	N/A	N/A	N/A
Harmony Biosciences Holdings, Inc. (HRMY)vs ›	$2.28B	5.30x	4.85x	7.14x	13.46x
Supernus Pharmaceuticals, Inc. (SUPN)vs ›	$2.47B	124.08x	54.29x	27.10x	23.78x
Alamar Biosciences, Inc. (ALMR)vs ›	$2.19B	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

NRIX EV/FCF Ratio History

DATE	EV/FCF RATIO
2021-02-16	134.51x
2021-02-12	127.30x
2021-02-11	129.19x
2021-02-10	126.92x
2021-02-09	128.36x
2021-02-08	125.09x
2021-02-05	128.14x
2021-02-04	113.38x
2021-02-03	124.48x
2021-02-02	132.79x
2021-02-01	114.60x
2021-01-29	114.82x
2021-01-28	121.20x
2021-01-27	131.08x
2021-01-26	163.02x
2021-01-25	169.90x
2021-01-22	168.46x
2021-01-21	157.09x
2021-01-20	154.31x
2021-01-19	191.31x
2021-01-15	160.58x
2021-01-14	149.60x
2021-01-13	143.66x
2021-01-12	140.50x
2021-01-11	136.57x
2021-01-08	136.23x
2021-01-07	110.61x
2021-01-06	85.15x
2021-01-05	90.31x
2021-01-04	93.69x
2020-12-31	95.41x
2020-12-30	108.83x
2020-12-29	120.87x
2020-12-28	139.56x
2020-12-24	156.20x
2020-12-23	164.19x
2020-12-22	164.57x
2020-12-21	112.72x
2020-12-18	112.77x
2020-12-17	156.59x
2020-12-16	135.79x
2020-12-15	155.26x
2020-12-14	181.71x
2020-12-11	133.35x
2020-12-10	151.43x
2020-12-09	141.78x
2020-12-08	161.63x
2020-12-07	155.37x
2020-12-04	151.93x
2020-12-03	157.09x
2020-12-02	153.87x
2020-12-01	151.98x
2020-11-30	149.43x
2020-11-27	130.69x
2020-11-25	122.70x
2020-11-24	127.75x
2020-11-23	120.26x
2020-11-20	121.81x
2020-11-19	104.51x
2020-11-18	102.57x
2020-11-17	98.08x
2020-11-16	90.98x
2020-11-13	75.28x
2020-11-12	74.34x
2020-11-11	67.41x
2020-11-10	52.26x
2020-11-09	39.79x
2020-11-06	41.67x
2020-11-05	53.04x
2020-11-04	52.15x
2020-11-03	51.99x
2020-11-02	52.38x
2020-10-30	53.32x
2020-10-29	58.14x
2020-10-28	58.92x
2020-10-27	72.23x
2020-10-26	65.24x
2020-10-23	70.12x
2020-10-22	63.02x
2020-10-21	62.30x
2020-10-20	60.53x
2020-10-19	60.25x
2020-10-16	54.76x
2020-10-15	48.16x
2020-10-14	14.96x
2020-10-13	15.65x
2020-10-12	15.42x
2020-10-09	14.78x
2020-10-08	15.81x
2020-10-07	15.83x
2020-10-06	15.89x
2020-10-05	16.11x
2020-10-02	16.32x
2020-10-01	19.65x
2020-09-30	22.61x
2020-09-29	21.42x
2020-09-28	20.08x
2020-09-25	19.46x
2020-09-24	17.77x
2020-09-23	18.59x
2020-09-22	19.43x
2020-09-21	19.67x
2020-09-18	22.45x
2020-09-17	20.22x
2020-09-16	19.05x
2020-09-15	18.67x
2020-09-14	19.85x
2020-09-11	18.81x
2020-09-10	17.72x
2020-09-09	16.43x
2020-09-08	15.91x
2020-09-04	15.43x
2020-09-03	15.58x
2020-09-02	17.81x
2020-09-01	16.92x
2020-08-31	14.03x
2020-08-28	14.26x
2020-08-27	13.30x
2020-08-26	13.73x
2020-08-25	13.67x
2020-08-24	14.14x
2020-08-21	16.61x
2020-08-20	17.63x
2020-08-19	18.36x
2020-08-18	17.26x
2020-08-17	16.71x
2020-08-14	14.39x
2020-08-13	15.20x
2020-08-12	10.18x
2020-08-11	8.55x
2020-08-10	9.81x
2020-08-07	10.18x
2020-08-06	9.72x
2020-08-05	9.63x
2020-08-04	10.44x
2020-08-03	10.84x
2020-07-31	11.04x
2020-07-30	10.78x
2020-07-29	10.95x
2020-07-28	10.70x
2020-07-27	11.18x
2020-07-24	10.76x

EV/FCF Ratio: N/A

NRIX EV/FCF Ratio Chart

NRIX EV/FCF Ratio Metrics

NRIX Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

NRIX EV/FCF Ratio History

Related Metrics